References
- Barzon L, Trevisan M, Sinigaglia A, et al. Zika virus: from pathogenesis to disease control. FEMS Microbiol Lett. 2016;363(18):pii: fnw202.
- PAHO/WHO. Zika cumulative cases. 2017 June 8 [cited 2017 June 13]. Available from: http://www.paho.org/hq/index.php?option=com_content&view=article&id=12390&Itemid=42090&lang=en
- European Centre for Disease Prevention and Control. Rapid risk assessment. Zika virus disease epidemic. Tenth update, 4 April 2017. Stockholm: ECDC; 2017.
- Honein MA, Dawson AL, Petersen EE, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. Jama. 2017;317:59–68.
- Larocca RA, Abbink P, Peron JP, et al. Vaccine protection against Zika virus from Brazil. Nature. 2016;536:474–478.
- Abbink P, Larocca RA, De La Barrera RA, et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 2016;353:1129–1132.
- Sumathy K, Kulkarni B, Gondu RK, et al. Protective efficacy of Zika vaccine in AG129 mouse model. Sci Rep. 2017;7:46375. DOI:10.1038/srep46375
- Kim E, Erdos G, Huang S, et al. Preventative vaccines for Zika virus outbreak: preliminary evaluation. EBioMedicine. 2016;13:315–320.
- Dowd KA, Ko SY, Morabito KM, et al. Rapid development of a DNA vaccine for Zika virus. Science. 2016;354:237–240.
- Muthumani K, Griffin BD, Agarwal S, et al. In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. Npj Vaccines. 2016;1:16021. DOI:10.1038/npjvaccines.2016.21
- Boigard H, Alimova A, Martin GR, et al. Zika virus-like particle (VLP) based vaccine. Plos Negl Trop Dis. 2017;11(5):e0005608.
- Chahal JS, Fang T, Woodham AW, et al. An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model. Sci Rep. 2017;7(1):252. DOI:10.1038/s41598-017-00193-w
- Pardi N, Hogan MJ, Pelc RS, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017;543(7644):248–251.
- Richner JM, Himansu S, Dowd KA, et al. Modified mRNA vaccines protect against Zika virus infection. Cell. 2017 Mar 23;169(1):176. DOI:10.1016/j.cell.2017.03.016
- Shan C, Muruato AE, Nunes BT, et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med. 2017 Apr 10;23:763–767. DOI:10.1038/nm.4322
- Betancourt D, de Queiroz NM, Xia T, et al. Cutting edge: innate immune augmenting vesicular stomatitis virus expressing Zika virus proteins confers protective immunity. J Immunol. 2017;198:3023–3028.
- Xie X, Yang Y, Muruato AE, et al. Understanding Zika virus stability and developing a chimeric vaccine through functional analysis. MBio. 2017;8(1):pii: e02134-16. DOI:10.1128/mBio.02134-16
- Screaton G, Mongkolsapaya J, Yacoub S, et al. New insights into the immunopathology and control of dengue virus infection. Nat Rev Immunol. 2015;15:745–759.
- Griffin BD, Muthumani K, Warner BR, et al. DNA vaccination protects mice against Zika virus-induced damage to the testes. Nat Commun. 2017;8:15743. DOI:10.1038/ncomms15743
- Morrison TE, Diamond MS. Animal models of Zika virus infection, pathogenesis, and immunity. J Virol. 2017;91(8):pii: e00009-17. DOI:10.1128/JVI.00009-17
- Stettler K, Beltramello M, Espinosa DA, et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353:823–826.